VANGUARD GROUP INC - TRILLIUM THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$9,742,000
+151.5%
554,749
+38.9%
0.00%–
Q2 2021$3,873,000
+405.6%
399,299
+459.8%
0.00%–
Q1 2021$766,000
-22.9%
71,333
+5.7%
0.00%–
Q4 2020$993,000–67,467–0.00%–
 Download
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders